Delivery Order 36C26320D0038-36C26324N0038
- Not listed
- This federal contract award to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, is for the delivery of single-dose radiopharmaceuticals to support nuclear medicine diagnostic imaging procedures at U.S. Department of Veterans Affairs (VA) medical facilities across Veterans Integrated Service Network (VISN) 23. The $56,752.27 firm-fixed-price delivery order was awarded on October 1, 2022, with a completion date of September 30, 2023. Pharmalogic Puerto Rico is a for-profit...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9), awarded a delivery order to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico) on October 1, 2024, with a ceiling value of $2.61 million. This firm fixed-price delivery order represents the first ordering period under a Physician-Supplied Medical Applicator (PSMA) contract and reflects a $2,008.72 decrease from the original amount. The contract is not set aside for any specific business...
- This is a federal contract award to Pharmalogic Holdings Corp., a for-profit company based in Boca Raton, Florida, to provide single-dose radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $96,546.45 and is a delivery order contract with a firm fixed price. The ultimate completion date is February 28, 2025. This contract is not a set-aside award. Pharmalogic Holdings Corp. specializes in supplying radiopharmaceuticals and related products to...
- This federal contract award was made by the Veterans Integrated Service Network 23 (VISN 23), a civilian agency that is part of the U.S. Department of Veterans Affairs (VA), to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico. The $200,255.59 firm-fixed-price delivery order contract is for the supply of radiopharmaceuticals and was not set aside for any specific business category. Pharmalogic Holdings Corp. is a for-profit organization that specializes in providing nuclear...
- Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, has been awarded a $181,940.77 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23. Under this contract, Pharmalogic will provide single dose radiopharmaceuticals to support the healthcare services and programs of VISN 23. Performance will take place in Southwest Meade, South Dakota, with an estimated completion date of February...
- Pharmalogic Holdings Corp., operating as Pharmalogic Puerto Rico, received a federal contract award on March 15, 2026, from the Veterans Integrated Service Network 9 (VISN 9) to supply F18-florbetapir (NeuraCeq) radiopharmaceutical unit doses for use in neurological diagnostic imaging at VA medical facilities. This Blanket Purchase Agreement (BPA) call contract carries a ceiling value of $628,875 and extends through March 14, 2030. The contract utilizes a fixed-price with economic price...
- This federal contract award to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, was issued by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network (VISN) 23. The $45,404.73 firm-fixed-price delivery order is for the provision of single-dose radiopharmaceuticals and generator nuclear medicine products to support nuclear medicine diagnostic imaging procedures at VA medical facilities. This award is part of a larger $2,664,954.52...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, to provide single dose radiopharmaceuticals. The contract has a ceiling value of $196,214.82 and a period of performance through February 28, 2022. Pharmalogic Puerto Rico was previously awarded an indefinite-delivery contract by VISN 23 to provide single dose...
- The Department of Veterans Affairs (VA), Veterans Integrated Service Network 12 (VISN 12), has awarded a firm-fixed-price purchase order contract to Pharmalogic Holdings Corp., operating under the trade name Pharmalogic Puerto Rico, for the supply of Fludeoxyglucose F 18 (18F-FDG) unit dose PET/CT radiopharmaceuticals for diagnostic patient care at the Clement J. Zablocki VA Medical Center in Milwaukee, Wisconsin. The contract has a ceiling value of $410,347.25 and a period of performance...
- This is a firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a division of the U.S. Department of Veterans Affairs (VA), to Pharmalogic Holdings Corp., a for-profit organization based in Boca Raton, Florida, operating under the trade name Pharmalogic Puerto Rico. The contract, valued at $156,162.68, is for the supply of nuclear generators and is set to run through September 30, 2025. The contract was not set aside for any specific business...
- 36C26320D0038Indefinite Delivery Contract
- 36C26320D0038-36C26324N0038Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a delivery order contract to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico) for single-dose radiopharmaceuticals with a ceiling value of approximately $191k. The contract, awarded on October 1, 2023, with an ultimate completion date of September 30, 2024, was issued on a firm fixed-price basis with no set-aside designation. The work will be performed in Highland Beach, Florida. Pharmalogic Holdings Corp. is a for-profit radiopharmaceutical supplier based in Boca Raton, Florida, that specializes in providing nuclear medicine diagnostic imaging products to VA facilities across multiple regional networks. This delivery order represents a continuation of Pharmalogic's established relationship with VISN 23, part of the VA's broader commitment to ensuring reliable access to advanced medical imaging products for veteran healthcare services. The company has demonstrated expertise in supplying specialized radiopharmaceuticals including Fludeoxyglucose F-18, PYLARIFY F-18 piflufolastat for prostate cancer imaging, and F-18 florbetapir for neurological diagnostics. The deobligation of excess funds noted in the contract description indicates adjustment to previously obligated amounts under this delivery order vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($26k) | 9/12/25 | |
| P00001 | Other Administrative Action | $0 | 10/5/23 | |
| Not listed | Not listed | $217.4k | 10/1/23 |